Imspex Diagnostics Ltd and Biophys Limited are pleased to announce a new phase in their collaborative journey, focused on advancing clinical and applied industry solutions through shared expertise and resources. With the recent opening of Biophys’s Class 2 laboratory at Mamhilad Park Estate, South Wales, this state-of-the-art Class 2 facility now offers quality-driven microbiological and R&D laboratory services to a variety of industries and is already supporting ongoing research projects for UK clients and Imspex.

This collaboration combines extensive capabilities in testing solutions, data collection, and advanced analytics. Together, they are pioneering innovative SMART NextGenDiagnostics, enhancing testing and analysis services across clinical and industrial sectors. By integrating our expertise, Imspex and Biophys are ideally positioned to bring transformative diagnostics solutions to market.

Looking ahead, there are opportunities for further expansion, including the integration of Imspex’s GC-IMS technology to develop new commercial applications in diagnostics for client’s testing needs. This partnership not only broadens Imspex’s service offerings, but also establishes the Biophys laboratory as a significant Life Sciences centre of excellence in Wales, providing local access to specialised laboratories and office space for R&D.

Together, Imspex and Biophys are committed to driving innovation and delivering quality solutions across industries, underscoring our shared mission to lead advancements in advanced diagnostics, chemical and microbiological analysis.